Sfoglia per AUTORE
ORTEGA C
Collezione ASL Cuneo 2

  

Items : 38

[What patients with cancer think about the dehospitalization. A survey of Cipomo.]. in Recenti progressi in medicina / Recenti Prog Med. 2024 May;115(5):232-237. doi: 10.1701/4262.42402.
2024
ASL Cuneo 2

Barni S; Aschele C; Blasi L; Giordano M; Ortega C; Pinotti G; Artioli F; Fioretto L; Daniele B; Aprile G; Silva RR; Montesarchio V;

2024
ASL Cuneo 2
AOU Novara

Porta C; Battelli N; Bracarda S; Sorgentoni G; Monteiro FSM; Mollica V; Rizzo A; Zabalza IO; Bimbatti D; Soares A; Bisonni R; Rebuzzi SE; Roviello G; Incorvaia L; Morelli F; Santini D; Vau N; Bhuva D; Küronya Z; Mosca A; Landmesser J; Milella M; Messina C; Bassanelli M; Ortega C; Grillone F; Procopio G; Sunela K; Caffo O; et alii...

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2024 Apr 18;73(6):106. doi: 10.1007/s00262-024-03682-w.
2024
ASL Cuneo 2

Mosca A; Morelli F; Bisonni R; Bamias A; Santini D; Herchhorn D; Kanesvaran R; Inman E; Caitano M; Messina C; Martignetti A; Kopecky J; Milella M; Procopio G; Abahssain H; Roviello G; Kopp RM; Bassanelli M; Fernandez M; Cutuli HJ; Grillone F; Aceituno LG; Seront E; de Carvalho Fernandes R; Nogueira L; Mennitto A; Dauster B; Monteiro FSM; Barillas A; et alii...

TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2024 Apr;22(2):56-67.e16. doi: 10.1016/j.clgc.2023.08.006. Epub 2023 Sep 7.
2024
ASL Città di Torino
AO Cuneo
ASL Asti
ASL Cuneo 2
AOU Città della Salute di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Filippi R; Brusa F; Prati V; Vana F; Mennitto A; Maio MD; Buttigliero C; Vignani F; Dionisio R; Icardi M; Guglielmini P; Buosi R; Stevani I; Vormola R; Numico G; Depetris I; Comandone A; Gennari A; Airoldi M; Rossi M; Vellani G; Ortega C; Ruatta F; Tucci M; Pisano C; Turco F; Arnaudo E; Fea E; Vanella P; et alii...

2024
ASL Cuneo 2
ASL Asti

Giannatempo P; Polymeropoulos A; Stellato M; Ambrosini P; Gusmaroli E; Cavalli C; Guadalupi V; Claps M; Raggi D; Rametta A; Ortega C; Tucci M; Buti S; Pipitone S; Iacovelli R; Calareso G; Alessi A; Procopio G; Miceli R; Necchi A;

2024
ASL Cuneo 2
ASL Asti

Stellato M; Giannatempo P; Polymeropoulos A; Guadalupi V; Claps M; Ambrosini P; Raggi D; Rametta A; Cavalli C; Gusmaroli E; Ortega C; Tucci M; Buti S; Pipitone S; Iacovelli R; Calareso G; Alessi A; Procopio G; Miceli R; Necchi A;

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2023 Nov;72(11):3665-3682. doi: 10.1007/s00262-023-03518-z. Epub 2023 Sep
2023
ASL Cuneo 2
AOU Novara

Santoni M; Porta C; Bellmunt J; Battelli N; Sorgentoni G; Landmesser J; Rizzo A; Mollica V; Zabalza IO; Zgura A; Incorvaia L; Ansari J; Pinto A; Soares A; Nunes F; Maluf F; Morelli F; Mosca A; Zakopoulou R; Bisonni R; Manneh R; Santini D; Inman E; Herchenhorn D; Kanesvaran R; Caitano M; Milella M; Kopecky J; Martignetti A; et alii...

Implementation of Precision Oncology in Clinical Practice: Results of a National Survey for Health Care Professionals. in The oncologist / Oncologist. 2023 Jun 2;28(6):e324-e330. doi: 10.1093/oncolo/oyad020.
2023
ASL Cuneo 2

Aprile G; Cavanna L; Tozzi VD; Silva RR; Ortega C; Giordano M; Pinto C; Daniele B; Grossi F; Barducci MC; Pelizzari G; Fasola G;

Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study. in Journal of the National Cancer Institute / J Natl Cancer Inst. 2023 Jul 6;115(7):796-804. doi: 10.1093/jnci/djad061.
2023
ASL Cuneo 2
AOU Alessandria

Ascierto PA; Aerts JGJV; Grossi F; Rocchi MBL; Cortellini A; Antonuzzo L; Indini A; Santini D; Addeo A; Lo Russo G; Rijavec E; Santoni M; Citarella F; Puglisi F; Manglaviti S; Garutti M; Sergi MC; Tucci M; Giusti R; Acquati M; Filetti M; Cortinovis D; Festino L; Di Giacomo AM; Veccia A; Leporati R; Scagnoli S; Belluomini L; Botticelli A; et alii...

An Italian multicenter retrospective real-life analysis of patients with brain metastases from renal cell carcinoma: the BMRCC study. in ESMO open / ESMO Open. 2023 Aug;8(4):101598. doi: 10.1016/j.esmoop.2023.101598. Epub 2023 Jul 17.
2023
AO Cuneo
ASL Cuneo 2

Porta C; Rizzo M; Trerotoli P; Funaioli C; Ricotta R; Santoni M; Ortega C; Giron Berrios JR; Facchini G; Incorvaia L; Zanardi E; Stellato M; Fornarini G; Galli L; Atzori F; Passarelli A; Bersanelli M; Procopio G; Bracarda S; Caffo O; Rudà R; Maiorano BA; Massari F; Internò V;

Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations. in Minerva urology and nephrology / Minerva Urol Nephrol. 2023 Aug;75(4):460-470. doi: 10.23736/S2724-6051.23.05369-7.
2023
AO Cuneo
ASL Cuneo 2
AOU Novara

Grande E; Santoni M; Buti S; Battelli N; Sorgentoni G; Pierantoni F; Monteiro FS; Rebuzzi SE; Roviello G; Soares A; Zabalza IO; Rizzo A; Bisonni R; Morelli F; Incorvaia L; Küronya Z; Mosca A; Bhuva D; Santini D; Vau N; Messina C; Merler S; Landmesser J; Grillone F; Ortega C; Sunela K; Ansari J; Atzori F; Bassanelli M; et alii...

2023
ASL Cuneo 2

Giannatempo P; Bottiglieri A; Guadalupi V; Marandino L; Raggi D; Stellato M; Rametta A; Baciarello G; Sepe P; Claps M; Buti S; Pipitone S; Iacovelli R; Calareso G; Alessi A; Cattaneo L; Verzoni E; Ortega C; Procopio G; Necchi A;

New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine? in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jun;174:103682. doi: 10.1016/j.critrevonc.2022.103682. Epub 2022 Apr 11
2022
ASL Asti
ASL Torino 4
ASL Cuneo 1
ASL Cuneo 2
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Scagliotti GV; Di Maio M; Ortega C; Di Prima L; Audisio A; Turco F; Ungaro A; Parlagreco E; Di Stefano RF; Audisio M; Tucci M;

MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma. in Journal of clinical pathology / J Clin Pathol. 2022 Jan;75(1):39-44. doi: 10.1136/jclinpath-2020-207089. Epub 2020 Nov 3.
2022
ASL Cuneo 2
ASL Cuneo 1
ASL Asti

Antonelli A; Munari E; Pappagallo G; Iacovelli R; Mosca A; Porta C; Martignoni G; Alongi F; Perrucci B; Giganti MO; Donini M; Panni S; Tucci M; Prati V; Ortega C; Caliò A; Procopio G; Verzoni E; Bracarda S; Sabbatini R; Baldessari C; Eccher A; Passalacqua R; Rebuzzi SE; Fornarini G; Vellone VG; Bersanelli M; Buti S; Zivi A; et alii...

Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation-based therapy. in Cancer communications (London, England) / Cancer Commun (Lond). 2022 Aug;42(8):683-688. doi: 10.1002/cac2.12340. Epub 2022 Jul 22.
2022
ASL Asti
ASL Cuneo 2
ASL Torino 4
ASL Cuneo 1
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Turco F; Ungaro A; Audisio M; Scagliotti GV; Di Maio M; Delcuratolo MD; Audisio A; Ortega C; Pisano C; Buttigliero C; Di Stefano RF; Tucci M;

2022
ASL Asti
AOU Città della Salute di Torino
ASL Cuneo 1
ASL Cuneo 2

Antonelli A; Porta C; Delahunt B; Giannarini G; Signori A; Banna GL; Rescigno P; Obispo MAL; Bortolus R; Perris R; Scaltriti M; Moch H; Fassan M; Dei Tos AP; Colecchia M; Franco R; Zito-Marino F; Aberasturi Plata Y; Galuppini F; Sbaraglia M; Bollito E; Cossarizza A; Massari F; Salvioni R; Rizzo M; Conti G; Lapini A; Colombo P; Patriarca C; et alii...

2022
ASL Cuneo 2

Fasola G; Barducci MC; Pelizzari G; Aprile G; Grossi F; Pinto C; Daniele B; Giordano M; Ortega C; Silva RR; Tozzi V; Cavanna L;

2021
AO Cuneo
ASL Asti
ASL Biella
ASL Cuneo 2
AOU Città della Salute di Torino
ASL Città di Torino
AOU Novara

Tucci M; Baier S; Gennari A; Bellissimo AR; Ciccone G; Masini C; Sacco C; Amoroso D; Montagnani F; Comandone A; Ortega C; Buttigliero C; Fea E; Vanella P; Valcamonico F; Zamparini M; Sirotova Z; Chiappino I; Bianchi S; Mosca A; Dalla Volta A; Prati V; Dal Canton O; Berruti A;

Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trial. in Expert review of clinical pharmacology / Expert Rev Clin Pharmacol. 2021 Feb;14(2):261-268. doi: 10.1080/17512433.2021.1879639. Epub 2021 Jan
2021
ASL Cuneo 2

Procopio G; de Braud FG; Cappelletti V; Guadalupi V; Sepe P; Claps M; Donini M; Ortega C; Atzori F; Morelli F; Bearz A; Miceli R; Chiuri VE; Mosca A; Milella M; Mennitto A; Verzoni E; Cognetti F;

The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer. in Liver international : official journal of the International Association for the Study of the Liver / Liver Int. 2020 Mar;40(3):704-711. doi: 10.1111/liv.14314. Epub 2019 Dec 11.
2020
ASL Cuneo 2
ASL Biella
AOU Città della Salute di Torino
AO Ordine Mauriziano

Casadei-Gardini A; Aprile G; Roviello G; Scartozzi M; Cascinu S; Silvestris N; Spallanzani A; Santini D; Gelsomino F; Depetris I; Cagnazzo C; Lombardi P; Fenocchio E; Sperti E; Di Maio M; Ortega C; Fornaro L; Aglietta M; Leone F; Cerma K; Salani F; Caputo F; Vivaldi C; Filippi R; Salati M;

Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 Jun;132:17-23. doi: 10.1016/j.ejca.2020.03.024. Epub 2020 Apr 6.
2020
ASL Cuneo 2
ASL Biella

Grossi F; Scanni A; Blasi L; Zamagni C; Pinotti G; Ortega C; Montesarchio V; Giordano M; Fiorentini G; Cavanna L; Clerico M; Fioretto L; Daniele B; Indini A; Aschele C;

2020
ASL Biella
ASL Città di Torino
ASL Asti
AO Cuneo
ASL Cuneo 2
AOU Città della Salute di Torino

Fea E; Buttigliero C; Montagnani F; Comandone A; Gennari A; Tucci M; Chiappino I; Canton OD; Masini C; Sacco† C; Amoroso D; Sirotova Z; Ciccone G; Valcamonico F; Vanella P; Ortega C; Prati V; Bianchi S; Mosca A; Berruti A;

2020
ASL Cuneo 2

Verzoni E; Claps M; Apollonio G; Guadalupi V; Montone R; Martinetti A; Sepe P; Mennitto A; Passalacqua R; Donini M; Atzori F; Ortega C; Morelli F; Bearz A; Chiuri VE; Mosca A; Milella M; Miceli R; Cognetti F; Procopio G;

2020
ASL Cuneo 2
AOU San Luigi di Orbassano

Vitale MG; Zucali PA; Milella M; Santoni M; Procopio G; Ortega C; Naglieri E; Massari F; Fornarini G; Di Lorenzo G; Chiuri VE; Calabro F; Fantinel E; Buttigliero C; Bracarda S; Bonomi L; Bersanelli M; Basso U; Atzori F; Iacovelli R;

Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2019 Jul 1;25(13):3839-3846. doi: 10.1158/1078-0432.CCR-18-3661. Epub 2019 Apr 9.
2019
ASL Cuneo 2
AO Cuneo

Sternberg CN; Caserta C; Cartenì G; Fornarini G; Verusio C; Scoppola A; Crinò L; Frassoldati A; Mini E; Marchetti P; Ortega C; Bidoli P; Ferraù F; Mitterer M; Sabbatini R; Bearz A; Buti S; Basso U; Procopio G; De Giorgi U; Giannarelli D;

Management of kidney cancer patients: 2018 guidelines of the Italian Medical Oncology Association (AIOM). in Tumori / Tumori. 2019 Jul;105(4_suppl):3-12. doi: 10.1177/0300891619853392.
2019
ASL Cuneo 2

Cartenì G; Gori S; Nolè F; Pignata S; Conti G; Guida M; Martignoni G; Pappagallo GL; Romano L; Sepe P; Porta C; Procopio G; Ortega C; Passalacqua R; Montironi R; Martorana G; Masini C; Lapini A; Mandressi A; Di Lorenzo G; Cosmai L; Crocetti E; Bracarda S; Vitale MG;

2019
ASL Cuneo 2
AO Cuneo

Piva F; Cimadamore A; Montironi R; Battelli N; Rizzo M; Merler S; Sorgentoni G; Conti A; Verzoni E; Scagliarini S; Sepe P; Cheng L; Paolucci V; Graham J; Pierce E; Lopez-Beltran A; Atzori F; Scarpelli M; Ortega C; Incorvaia L; Vau N; Iacovelli R; Mosca A; Gelibter A; Carrozza F; Martignetti A; Morelli F; Caffo O; Zucali P; et alii...

2019
ASL Cuneo 2

De Giorgi U; Procopio G; Sabbatini R; Caserta C; Mitterer M; Ortega C; Scoppola A; Fornarini G; Ferraú F; Marchetti P; Verusio C; Mini E; Bidoli P; Buti S; Crino L; Basso U; Frassoldati A; Bearz A; Carteni G; Sternberg CN;

2019
ASL Cuneo 2

Procopio G; Di Cosimo S; De Giorgi U; Cartenì G; Cortesi E; Caserta C; Sabbatini R; Bearz A; Buti S; Pignata S; Berruti A; Ruggeri E; Bengala C; Livi L; Fagnani D; Bonetti A; Mitterer M; Ortega C; Cognetti F; Di Nicola MA;

2018
ASL Cuneo 2

Brunelli M; Martignoni G; Ortega C; Lapini A; Cima L; Porta C; Iacovelli R; Tortora G; Ardizzoni A; Guida A; Sanguedolce F; Sabbatini R; D'Amuri A; Giunchi F; Fiorentino M; Caliò A; Hes O; Michal M; Ciccarese C; Massari F;

Cardiovascular safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients: a prospective evaluation. in Future oncology (London, England) / Future Oncol. 2018 Feb;14(5):443-448. doi: 10.2217/fon-2017-0385. Epub 2018 Jan 10.
2018
ASL Cuneo 2

Aglietta M; Ortega C; Marandino L; Nuzzolese I; Torino S; Bonzano A; Galizia D; Gernone A; Aversa C; Ruatta F; Prati V;

Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2018 Aug;16(4):e945-e951. doi: 10.1016/j.clgc.2018.03.014. Epub 2018 Apr 19.
2018
ASL Cuneo 2
AOU San Luigi di Orbassano

Facchini G; Cartenì G; Sabbatini R; Del Bene G; Galli L; Caserta C; Multari AG; Bregni M; Massari F; Buti S; De Giorgi U; Zustovich F; Milella M; Calabrò F; Mancini ML; Tortora G; Vernieri C; Santini D; Sorarù M; Ricotta R; Masini C; Tucci M; Fedeli SL; Ortega C; Mecozzi A; Ratta R; Sternberg CN; Verzoni E; Fornarini G; et alii...

2018
ASL Cuneo 2

Procopio G; Cognetti F; Miceli R; Milella M; Mosca A; Chiuri VE; Bearz A; Morelli F; Ortega C; Atzori F; Donini M; Ratta R; Martinetti A; Montone R; De Braud FG; Cappelletti V; Verzoni E;

2018
ASL Cuneo 2

Sirotova Z; Courthod G; Tartarone A; Caffo O; Maines F; Prati V; Bertuccelli M; Mosca A; Fornarini G; Guglielmini P; Morelli F; Palesandro E; Ortega C; Miraglia S; Perrone V; Numico G; Allegrini G; Aieta M; Schena M;

2018
ASL Cuneo 2

Sirotova Z; Courthod G; Tartarone A; Caffo O; Maines F; Bertuccelli M; Morelli F; Numico G; Guglielmini P; Fornarini G; Prati V; Palesandro E; Ortega C; Mosca A; Miraglia S; Perrone V; Fea E; Allegrini G; Mozzicafreddo A; Schena M;

2017
ASL Cuneo 2

Ricotti A; Ortega C; Brioschi E; Canavese P; Pierini A; Cassissa G; Bono D; Bertetto O; Messori Ioli G;

2017
ASL Cuneo 2

Procopio G; Prisciandaro M; Iacovelli R; Mancini M; Fornarini G; Facchini G; Cartení G; Napolitano M; Sternberg CN; Caserta C; Bregni M; Massari F; Buti S; Biasco E; De Giorgi U; Zustovich F; Ratta R; Ortega C; Tortora G; Verzoni E;

2017
ASL Cuneo 2

Grassi P; Doucet L; Giglione P; Grünwald V; Melichar B; Galli L; De Giorgi U; Sabbatini R; Ortega C; Santoni M; Bamias A; Verzoni E; Derosa L; Studentova H; Porcu L; De Braud F; Porta C; Procopio G;